🇺🇸 FDA
Patent

US 12358885

Substituted n-propylamine fused heterocyclic mescaline derivatives

granted A61PA61P25/00

Quick answer

US patent 12358885 (Substituted n-propylamine fused heterocyclic mescaline derivatives) held by Enveric Biosciences Canada Inc. expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enveric Biosciences Canada Inc.
Grant date
Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P25/00